IL17A and Cognitive impairment: The study by Trenova et al. investigated the association between tumor necrosis factor (TNFα) alpha, interleukin (IL)-17A, IL-18, IL-10 protein levels, and cognitive impairment in patients with relapsing-remitting MS.